Neurodon Board Director Brunde Broady Releases New Book

About the book, Brunde Broady said, “Calcium ATPase is a critical component of good health. My goal is to provide the reader with research-based information on how to optimize their levels of this important enzyme and reduce their susceptibility to chronic diseases such as cancer, diabetes, obesity, cardiovascular disease, and Alzheimer’s.”

Neurodon CEO, Dr. Russell Dahl, said, “Brunde’s work delivers convincing and extensive evidence that calcium ATPase is a key contributor to health and disease. It also provides a substantial compendium of studies related to this important area.”

Neurodon Director of Operations, Colleen Mauger, R.N. said, “Brunde is dedicated to spreading awareness of the importance of calcium ATPase regulation and has been a key member of our Neurodon team.”